![Thomas Heineman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thomas Heineman
Chief Tech/Sci/R&D Officer at ONCOLYTICS BIOTECH INC.
Net worth: 552 334 $ as of 2024-05-30
Thomas Heineman active positions
Companies | Position | Start | End |
---|---|---|---|
ONCOLYTICS BIOTECH INC. | Chief Tech/Sci/R&D Officer | 2020-07-31 | - |
Career history of Thomas Heineman
Former positions of Thomas Heineman
Companies | Position | Start | End |
---|---|---|---|
Denovo Biopharma LLC
![]() Denovo Biopharma LLC Pharmaceuticals: MajorHealth Technology Denovo Biopharma LLC provides a novel biomarker solution to personalize drug development. It applies in oncology, metabolic, cardiology, immunology and neurology therapeutic areas. The company is headquartered in San Diego, CA. | Corporate Officer/Principal | 2019-12-31 | 2020-06-30 |
GENOCEA BIOSCIENCES, INC. | Corporate Officer/Principal | 2016-07-31 | 2019-12-31 |
HALOZYME THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2018-01-31 | 2019-12-31 |
Corporate Officer/Principal | 2018-01-31 | 2019-12-31 | |
GSK PLC | Chief Tech/Sci/R&D Officer | 2005-12-31 | 2016-07-31 |
Saint Louis University School of Medicine | Corporate Officer/Principal | - | - |
Training of Thomas Heineman
The University of Chicago | Doctorate Degree |
Statistics
International
United States | 6 |
Canada | 2 |
United Kingdom | 2 |
Operational
Corporate Officer/Principal | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Doctorate Degree | 1 |
Sectoral
Health Technology | 6 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 4 |
---|---|
ONCOLYTICS BIOTECH INC. | Health Technology |
GENOCEA BIOSCIENCES, INC. | Health Technology |
HALOZYME THERAPEUTICS, INC. | Health Technology |
GSK PLC | Health Technology |
Private companies | 1 |
---|---|
Denovo Biopharma LLC
![]() Denovo Biopharma LLC Pharmaceuticals: MajorHealth Technology Denovo Biopharma LLC provides a novel biomarker solution to personalize drug development. It applies in oncology, metabolic, cardiology, immunology and neurology therapeutic areas. The company is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Thomas Heineman
- Experience